Is NF-κB a culprit in type 2 diabetes?
- 24 June 2005
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 332 (1) , 1-3
- https://doi.org/10.1016/j.bbrc.2005.03.075
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- IKK-β links inflammation to obesity-induced insulin resistanceNature Medicine, 2005
- Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κBNature Medicine, 2005
- Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistanceInternational Journal of Obesity, 2003
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of IkkβScience, 2001
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- New Insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of DiseasesClinical Chemistry, 1999
- The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-βNature, 1998
- Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.Journal of Clinical Investigation, 1998
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- An inducible transcription factor activates expression of human immunodeficiency virus in T cellsNature, 1987